The STEP 4 withdrawal trial showed that most participants regained approximately two-thirds of lost weight within one year of discontinuation, confirming that semaglutide treats obesity chronically rather than curing it
By selectively activating amylin receptors involved in satiety and energy balance, Cagrilintide supports research into glucose regulation, caloric intake modulation, and sustained metabolic signaling
INTRODUCTION Glucagon-like peptide 1 (GLP-1) was identified as an incretin that influences critical physiological processes such as gastric emptying, food intake, and insulin secretion (1, 2)
The analysis found increased diagnoses of osteoporosis and osteomalacia, both conditions that weaken bones and raise the likelihood of fractures
Here, we analyze the distinct molecular regulation of autophagy by glucagon, GLP-1, and DPP-4 inhibitors